Search results for "Antigen-presenting cell"

showing 10 items of 279 documents

Synovial fluid-derivedYersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells

1991

Humoral and cellular immune reactions to heat-shock proteins have been implicated in the pathogenesis of arthritis. Heat-shock proteins occur in bacteria as well as all eukaryotes and have been highly conserved during evolution. Cross-reactivity between bacterial and human heat-shock proteins induced at the site of inflammation may underlie the pathogenesis of some forms of arthritis. In order to test this hypothesis, we raised and cloned a Yersinia-specific T cell line from the synovial fluid lymphocytes of a patient with Yersinia-induced reactive arthritis. From this line we obtained a CD4+ T cell clone that proliferated in response to Yersinia antigens and both to the mycobacterial and t…

AdultMaleSalmonella typhimuriumHot TemperatureT-LymphocytesT cellImmunologyDose-Response Relationship ImmunologicAntigen-Presenting CellsArthritisCross ReactionsBiologyArthritis ReactiveImmune systemTetanus ToxinAntigenHeat shock proteinCandida albicansSynovial FluidEscherichia colimedicineHumansImmunology and AllergySynovial fluidAntigen-presenting cellHeat-Shock ProteinsT lymphocytebeta-Galactosidasemedicine.diseaseYersiniaCell biologymedicine.anatomical_structureImmunologyEuropean Journal of Immunology
researchProduct

Definition of discrete signals involved in human T-cell activation

1986

Abstract Mitogenic activities of monoclonal antibodies directed at denned receptor structures expressed on the surface of mature human T lymphocytes were employed to study, in detail, signals involved in primary T-cell activation. Based on differential requirements for stimulation, two discrete pathways of human T-cell activation can be defined: the antigen-induced mode of activation initiated through the Ti-T3 antigen-receptor complex and an alternative pathway which can be triggered by monoclonal antibodies directed at the T11 glycoprotein. Perhaps more importantly, the approach taken here allows the definition of stable intermediate cellular stages within the activation cascade and, thus…

Adultmedicine.drug_classT-LymphocytesT cellImmunologyReceptors Antigen T-CellAntigen-Presenting CellsStimulationBiologyLymphocyte ActivationMonoclonal antibodyMonocytesmedicineHumansReceptorMolecular Biologychemistry.chemical_classificationAntibodies MonoclonalCell biologySignallingmedicine.anatomical_structurechemistryAlternative complement pathwayInterleukin-2GlycoproteinInterleukin-1Molecular Immunology
researchProduct

B cells in the aged: CD27, CD5, and CD40 expression.

2003

Ageing is characterized by numerous changes in lymphocyte subpopulations. In the present paper we have focused on B cells carrying the surface markers CD27, CD5 and CD40. CD27 is considered a marker of primed (memory) cells and its engagement promotes the differentiation of memory B cells into plasma cells. CD5 is expressed on B1 cells, which are considered to be responsible for T cell-independent antibody production other than autoantibodies. The CD40 molecule binds CD40L (CD154) and is necessary for T-dependent antibody responses. Here we show that the absolute number of CD5+ and CD40+ B cells is decreased in the elderly, while CD27+ B lymphocytes only marginally decrease in centenarians.…

Adultmedicine.medical_specialtyAgingNaive B cellchemical and pharmacologic phenomenaCD5 AntigensNatural killer cellInterleukin 21immune system diseasesInternal medicinemedicineHumansLymphocyte CountCD154CD40 AntigensAntigen-presenting cellAgedAged 80 and overB-LymphocytesCD40biologyhemic and immune systemsMiddle AgedMolecular biologyTumor Necrosis Factor Receptor Superfamily Member 7B-1 cellmedicine.anatomical_structureEndocrinologybiology.proteinInterleukin 12BiomarkersDevelopmental BiologyMechanisms of ageing and development
researchProduct

Human Monocytes, but not Dendritic Cells Derived from Them, Are Defective in Base Excision Repair and Hypersensitive to Methylating Agents

2007

Abstract Monocytes and dendritic cells are key players in the immune response. Because dendritic cells drive the tumor host defense, it is important that monocytes and dendritic cells survive cytotoxic tumor therapy. Although most of the anticancer drugs target DNA, the DNA repair capacity of monocytes and dendritic cells has not yet been investigated. We studied the sensitivity of monocytes and monocyte-derived dendritic cells against various genotoxic agents and found monocytes to be more sensitive to overall cell kill and apoptosis upon exposure to methylating agents (e.g., N-methyl-N′-nitro-N-nitrosoguanidine, methyl methanesulfonate, and the anticancer drug temozolomide). On the other …

Alkylating AgentsMethylnitronitrosoguanidineCancer ResearchDNA RepairCell SurvivalDNA repairBiologyMonocytesDrug HypersensitivityXRCC1Immune systemTemozolomidemedicineHumansCytotoxic T cellAntigen-presenting cellCells CulturedMonocyteDendritic CellsBase excision repairDendritic cellDNA MethylationMethyl MethanesulfonateDacarbazinemedicine.anatomical_structureOncologyImmunologyCancer researchMutagensCancer Research
researchProduct

Mast Cells Induce Migration of Dendritic Cells in a Murine Model of Acute Allergic Airway Disease

2009

<i>Background: </i>The migration of dendritic cells (DCs) from the lungs to the regional lymph nodes is necessary for the development of allergic airway disease. Following activation, mast cells release a variety of stored or de novo-produced inflammatory mediators, several of them being capable of activating DCs. In this study, the role of mast cells on DC migration from the lungs to the thoracic lymph nodes was investigated in sensitized mice. <i>Methods:</i> Mast cell-deficient mice (Kit<sup>W-sh/W-sh</sup>) and their wild-type counterparts were sensitized intraperitoneally with ovalbumine (OVA) in saline and challenged by a single intranasal administr…

AllergyAdoptive cell transferOvalbuminImmunologyInflammationCell SeparationMiceAnimalsImmunology and AllergyMedicineMast CellsAntigen-presenting cellFollicular dendritic cellsbusiness.industryCell migrationDendritic CellsGeneral MedicineDendritic cellAllergensrespiratory systemFlow Cytometrymedicine.diseaseMast cellAdoptive Transferrespiratory tract diseasesChemotaxis Leukocytemedicine.anatomical_structureImmunologyBronchial Hyperreactivitymedicine.symptombusinessBronchoalveolar Lavage FluidInternational Archives of Allergy and Immunology
researchProduct

Mucosal immunoregulation: transcription factors as possible therapeutic targets.

2005

Much progress has been recently made with regard to our understanding of the mucosal immune system in health and disease. In particular, it has been shown that uncontrolled mucosal immune responses driven by lymphocytes or non-lymphoid cells may lead to immunological diseases such as allergy, hypersensitivity and inflammation. Thus, a more detailed understanding of mucosal immune regulation and decision making at mucosal surfaces is essential for a better understanding of mucosal immune responses in health and disease. Antigen presenting cells and T lymphocytes play a key role in controlling mucosal immune responses. To deal with this key task, T helper cells differentiate into functionally…

AllergyImmunologyInflammationApoptosisSuppressor of Cytokine Signaling ProteinsAllergic inflammationPathogenesisImmune systemImmunitymedicineHypersensitivityImmunology and AllergyAnimalsHumansIL-2 receptorMast CellsAntigen-presenting cellGlucocorticoidsImmunity MucosalPharmacologybusiness.industrymedicine.diseaseInflammatory Bowel DiseasesAsthmaIntestinesSuppressor of Cytokine Signaling 3 ProteinImmunologyCytokinesmedicine.symptombusinessTranscription FactorsCurrent drug targets. Inflammation and allergy
researchProduct

In vitro study of alloreactivity and microchimerism after injection of dendritic cells and anti-CD4 monoclonal antibody in a combination of Lewis-Wis…

1998

Anti-CD4 Monoclonal Antibodymedicine.drug_classT-LymphocytesAntigen presentationRats Inbred WFBiologyMonoclonal antibodyLymphocyte ActivationImmune toleranceIsoantibodiesmedicineAnimalsTransplantation HomologousAntigen-presenting cellTransplantationTransplantation ChimeraAntibodies MonoclonalMicrochimerismDendritic cellDendritic CellsIn vitroRatsRats Inbred LewImmunologyCD4 AntigensCancer researchSurgeryTransplantation proceedings
researchProduct

Induction of tolerogenic DCs: ‘you are what you eat’

2003

Abstract Dendritic cells (DCs) take up antigens using antigen receptors that can be divided into three major classes: C-type lectins, integrins and Fc receptors. These receptors facilitate effective presentation of MHC–peptide complexes to T cells, resulting in the induction of immune responses. However, we discuss recent evidence that some receptors also cause induction of tolerance. Signaling motifs within the receptors either block maturation of DCs or induce signals that render DCs tolerogenic. These DCs then either induce regulatory T cells or cause deletion of effector T cells, resulting in the induction of tolerance. Antigen receptors expressed by DCs might therefore have an importan…

Antigen PresentationbiologyEffectorImmunologyIntegrinModels ImmunologicalPeripheral tolerancechemical and pharmacologic phenomenaDendritic CellsImmune receptorReceptors AntigenImmune systemAntigenImmunologyImmune Tolerancebiology.proteinAnimalsHumansImmunology and AllergyReceptorAntigen-presenting cellSignal TransductionTrends in Immunology
researchProduct

Pathological role of IL-6 in the experimental allergic bronchial asthma in mice.

2005

Although allergic asthma was described to be associated with the presence of mucosal T helper (Th)2 cells, it is not entirely clear which factors are responsible for priming of T cells to differentiate into Th2 effector cells in this disease. Interleukin (IL)-6 has been recognized as important because it is secreted by cells of the innate immunity and induces the expansion of the Th2 effector cells, which are major players of the adaptive immune responses. Additionally, IL-6 released by dendritic cells (DCs) inhibits the suppressive function of CD4+CD25+ T regulatory cells, thus inhibiting the peripheral tolerance. The signal transduction of IL-6 has recently taught us how this cytokine inf…

Antigen presentationAntigen-Presenting CellsT-Lymphocytes RegulatoryInterleukin 21MiceHypersensitivityImmunology and AllergyMedicineAnimalsHumansIL-2 receptorAntigen-presenting cellLungInterleukin 3CD40biologybusiness.industryInterleukin-6Models ImmunologicalGeneral MedicineReceptors Interleukin-6AsthmaDisease Models AnimalInterleukin 15ImmunologyInterleukin 12biology.proteinbusinessSignal TransductionClinical reviews in allergyimmunology
researchProduct

The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells

2011

Abstract Abstract 2748 The tyrosine kinase inhibitors (TKIs) Imatinib mesylate (IM, Gleevec, Glivec) and nilotinib (NI, Tasigna, AMN) are currently used in treatment of chronic myeloid leukaemia (CML). IM has been described to influence the function and differentiation of antigen presenting cells, to inhibit the effector function of T lymphocytes and to decrease the immunogenicity of CML cells by downregulation of tumor associated antigens. In the present study, we analyzed the effect of IM and NI on proteasomal activity in IM-sensitive or IM/NI- resistant CML cells as well as in patient samples using a biotinylated active site-directed probe, which, covalently binds and labels proteasomal …

Antigen processingImmunologyTyrosine phosphorylationCell BiologyHematologyBiologyBiochemistryMolecular biologyEpitopechemistry.chemical_compoundImatinib mesylateAntigenchemistryPhosphorylationAntigen-presenting cellTyrosine kinaseBlood
researchProduct